These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 1596887)
1. Overexpression of cholecystokinin receptors in azaserine-induced neoplasms of the rat pancreas. Bell RH; Kuhlmann ET; Jensen RT; Longnecker DS Cancer Res; 1992 Jun; 52(12):3295-9. PubMed ID: 1596887 [TBL] [Abstract][Full Text] [Related]
2. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization. Zhou W; Povoski SP; Longnecker DS; Bell RH Cancer Res; 1992 Dec; 52(24):6905-11. PubMed ID: 1458479 [TBL] [Abstract][Full Text] [Related]
3. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719 [TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas. Povoski SP; Zhou W; Longnecker DS; Bell RH Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527 [TBL] [Abstract][Full Text] [Related]
5. Autoradiographic localization of cholecystokinin (CCK) receptor expression during the development of azaserine-induced rat pancreatic carcinoma. Tsuei BJ; Povoski SP; Zhou W; Bell RH Pancreas; 1996 Nov; 13(4):401-6. PubMed ID: 8899801 [TBL] [Abstract][Full Text] [Related]
6. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors. Zhou W; Povoski SP; Bell RH J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864 [TBL] [Abstract][Full Text] [Related]
7. Temporal expression of the gastrin (CCK-B) receptor during azaserine-induced pancreatic carcinogenesis. Povoski SP; Zhou W; Longnecker DS; Bell RH Pancreas; 1993 Sep; 8(5):615-21. PubMed ID: 8302799 [TBL] [Abstract][Full Text] [Related]
9. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas. Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631 [TBL] [Abstract][Full Text] [Related]
10. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702. Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411 [TBL] [Abstract][Full Text] [Related]
11. Gastrin receptor expression during azaserine-induced rat pancreatic carcinogenesis. Tsuei BJ; Povoski SP; Zhou W; Bell RH J Surg Res; 1996 Jun; 63(1):105-9. PubMed ID: 8661181 [TBL] [Abstract][Full Text] [Related]
12. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor. Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238 [TBL] [Abstract][Full Text] [Related]
13. Effects of dietary fats and soybean protein on azaserine-induced pancreatic carcinogenesis and plasma cholecystokinin in the rat. Roebuck BD; Kaplita PV; Edwards BR; Praissman M Cancer Res; 1987 Mar; 47(5):1333-8. PubMed ID: 3815341 [TBL] [Abstract][Full Text] [Related]
14. Nucleoside diphosphate kinase associated with rat pancreatic membranes regulates CCK receptor affinity. Blevins GT; van de Westerlo EM; Williams JA Am J Physiol; 1994 Nov; 267(5 Pt 1):G866-74. PubMed ID: 7977749 [TBL] [Abstract][Full Text] [Related]
15. Stimulation of pancreatic growth by cholecystokinin is mediated by high affinity receptors on rat pancreatic acinar cells. Dawra R; Saluja A; Lerch MM; Saluja M; Logsdon C; Steer M Biochem Biophys Res Commun; 1993 Jun; 193(3):814-20. PubMed ID: 8323557 [TBL] [Abstract][Full Text] [Related]
16. A reduced pancreatic protein secretion in response to cholecystokinin (CCK) in the obese Zucker rat correlates with a reduced receptor capacity for CCK. Praissman M; Izzo RS Endocrinology; 1986 Aug; 119(2):546-53. PubMed ID: 3015550 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of messenger RNA for cholecystokinin-A receptor and novel expression of messenger RNA for gastrin (cholecystokinin-B) receptor in azaserine-induced rat pancreatic carcinoma. Zhou W; Povoski SP; Bell RH Carcinogenesis; 1993 Oct; 14(10):2189-92. PubMed ID: 8222074 [TBL] [Abstract][Full Text] [Related]
18. CCKA receptor activation stimulates p130(Cas) tyrosine phosphorylation, translocation, and association with Crk in rat pancreatic acinar cells. Ferris HA; Tapia JA; GarcĂa LJ; Jensen RT Biochemistry; 1999 Feb; 38(5):1497-508. PubMed ID: 9931015 [TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin receptors and PANC-1 human pancreatic cancer cells. Smith JP; Rickabaugh CA; McLaughlin PJ; Zagon IS Am J Physiol; 1993 Jul; 265(1 Pt 1):G149-55. PubMed ID: 8338163 [TBL] [Abstract][Full Text] [Related]
20. Growth of azaserine-induced putative preneoplastic nodules in the rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH Ann N Y Acad Sci; 1994 Mar; 713():439-41. PubMed ID: 8018216 [No Abstract] [Full Text] [Related] [Next] [New Search]